Stay updated on Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Sign up to get notified when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.

Latest updates to the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page
- CheckyesterdayChange DetectedGaucher disease type I has been added as a related condition term on the study page.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous v3.4.2.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-status notice. The earlier Revision: v3.4.1 notice was also removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedNotice about a lapse in government funding and status updates (top-of-page notice) has been added, and the site revision note has been updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check66 days agoChange DetectedThe page adds a glossary toggle and QC metadata (Last Update Submitted that Met QC Criteria) along with revision information (Revision: v3.4.0). The previous labels and older revision (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) are removed.SummaryDifference0.2%

Stay in the know with updates to Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.